The National Cancer Institute (NCI) will hold its May 20–21. The meeting, which offers free registration, will focus on how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers; what co-clinical quantitative imaging information is currently available at NCI co-clinical imaging research resources; and applications of co-clinical imaging to oncology precision medicine.
The CIRP network was formed in 2018, based on a trans-NCI initiative, with a joint effort of the Cancer Imaging Program at the Division of Cancer Treatment and Diagnosis, the Division of Cancer Biology, and the Division of Cancer Prevention. The network’s mission is to advance precision medicine by establishing consensus-based best practices for co-clinical quantitative imaging to enable disease detection, risk stratification and assessment/prediction of response to therapy.
The meeting is hybrid, with in-person attendance at NCI’s Shady Grove, MD campus or virtual attendance. A call for posters is open to all CIRP and non-CIRP affiliated investigators pursuing research within the scientific scope of the CIRP network. Poster abstracts are due April 8, and for the meeting closes May 6.
For more information, contact Katie Grady, ® Government Affairs Director.
Presents to FDA on Oversight Considerations for GenAI Medical Devices
The ® presented at the U.S. FDA Digital Health Advisory Committee meeting “Total Product Lifecycle Considerations for Generative AI-Enabled Devices.” Bernardo Bizzo, MD, PhD, Data Science Institute® Associate Chief Science Officer, represented the College at the meeting.
Read moreDSI Releases 2 New Non-Interpretive Reading Room Use Cases
use cases, artificial intelligence, reading room
Read moreDirect Supervision for Contrast Studies
We recommend that sites follow the CT and MR Accreditation requirements for onsite supervision of contrast administration and management.
Read more